scholarly journals Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999

2001 ◽  
Vol 48 (3) ◽  
pp. 441-444 ◽  
Author(s):  
A. J. de Neeling
Vaccine ◽  
2016 ◽  
Vol 34 (4) ◽  
pp. 531-539 ◽  
Author(s):  
Astrid A.T.M. Bosch ◽  
Marlies A. van Houten ◽  
Jacob P. Bruin ◽  
Alienke J. Wijmenga-Monsuur ◽  
Krzysztof Trzciński ◽  
...  

Vaccine ◽  
2016 ◽  
Vol 34 (1) ◽  
pp. 4-6 ◽  
Author(s):  
Anna M.M. van Deursen ◽  
Menno R. van den Bergh ◽  
Elisabeth A.M. Sanders

1999 ◽  
Vol 42 (3) ◽  
pp. 185-192 ◽  
Author(s):  
B.E.de Galan ◽  
P.M.B.van Tilburg ◽  
M Sluijter ◽  
S.J.M Mol ◽  
R.de Groot ◽  
...  

2012 ◽  
Vol 67 (9) ◽  
pp. 2283-2288 ◽  
Author(s):  
H. M. Kwint ◽  
P. D. van der Linden ◽  
M. M. B. Roukens ◽  
S. Natsch ◽  

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Marvin AH Berrevoets ◽  
Jaap ten Oever ◽  
Tom Sprong ◽  
Reinier M van Hest ◽  
Ingeborg Groothuis ◽  
...  

2006 ◽  
Vol 27 (3) ◽  
pp. 299-301 ◽  
Author(s):  
Susan M. Farner

We sought to determine whether antimicrobial susceptibility data from a nonteaching community hospital could be used to detect statistically significant local increases in resistance among Streptococcus pneumoniae over a 5-year period. Minimum inhibitory concentrations (MICs) of penicillin and ceftriaxone from 1997-1998 were compared with those from 2000-2001. MICs of penicillin and ceftriaxone for organisms collected in a nonteaching community hospital in central Illinois were used for analysis. The hospital has 224 beds and a catchment area of approximately 40 miles. There were significant increases in MICs of penicillin and ceftriaxone between 1997-1998 and 2000-2001. The MIC of penicillin increased from 0.042 to 0.121 μg/mL (P = .001; 95% confidence interval, -1.713 to -0.388), and the MIC of ceftriaxone increased from 0.028 to 0.071μg/mL (P = .005; 95% confidence interval, -1.353 to -0.188). There were no significant changes in the percentage of S. pneumoniae isolates that were resistant, intermediate, or susceptible to penicillin and ceftriaxone. MIC data from a community hospital can be used to detect local increases in the rate of resistance before antibiogram data show significant changes. This information is important for demonstrating to physicians the need to review local antibiotic use in the attempt to slow the development of resistant organisms in the community.


Vaccine ◽  
2011 ◽  
Vol 29 (5) ◽  
pp. 1029-1035 ◽  
Author(s):  
K.E.M. Elberse ◽  
S.C. de Greeff ◽  
N. Wattimena ◽  
W. Chew ◽  
C.S. Schot ◽  
...  

2019 ◽  
Vol 18 (1) ◽  
pp. 69-79 ◽  
Author(s):  
David J. Mott ◽  
Grace Hampson ◽  
Martin J. Llewelyn ◽  
Jorge Mestre-Ferrandiz ◽  
Michael M. Hopkins

Abstract Background Novel diagnostics are needed to manage antimicrobial resistance (AMR). Patient preferences are important in determining whether diagnostic tests are successful in practice, but there are few data describing the test attributes which matter most to patients. We elicited patients’ preferences for attributes of diagnostic tests that could be used to reduce unnecessary antibiotic use in primary care across seven European countries. Methods We used an online stated preference survey, including a discrete choice experiment (DCE). The DCE explored how patients make trade-offs between three key attributes of diagnostic tests: the speed that results were available, confidence in the test results, and how convenient it is to take the test. Individuals were eligible to complete the survey if they had taken antibiotics within the last 2 years and were resident in Germany, Italy, Spain, France, Greece, the Netherlands or the United Kingdom (UK). Results In total, 988 respondents completed the survey. The DCE responses illustrated that speed was the least important attribute in most countries. Responses from Germany and the Netherlands indicated that confidence was most important in these countries. Responses from the UK, France, Spain and Italy showed convenience as the most important attribute in these countries. Two attributes, confidence and convenience, were jointly favoured by respondents in Greece. Conclusion Patients in different European countries do not have the same preferences for the attributes of diagnostic tests to manage AMR in primary care. Failure to account for such differences during test development could reduce test uptake, result in continued overuse of antibiotics, and hamper marketisation.


Sign in / Sign up

Export Citation Format

Share Document